Register or Sign in to Save this opportunity, or Send an Inquiry.
Compound for Treatment of Psoriasis
Health Technologies at Strathclyde United Kingdom flag United Kingdom
Abstract ID:
A proprietary compound that can be applied topically to reduce excessive proliferation of skin cells
Send an Inquiry
RE:
Participants
You

Background


Psoriasis is a skin disease characterised by inflammation and scaly lesions of the skin affecting 2-3% of the population in Europe and North America. Several different therapies are currently being used to treat psoriasis, but they all have the possibility of serious side effects. Additionally, they are expensive to produce and lack efficacy in some patients.


GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

Contact is welcomed from parties interested in this project.

FEATURED
Last Updated Feb 2014
Technology Type THERAPEUTIC
Phase of Development EARLY STAGE
UNIVERSITY

Opportunity Contact